Adherence to self-administered biologic disease-modifying antirheumatic drugs across health-system specialty pharmacies

Adherence to self-administered biologic disease-modifying antirheumatic drugs across health-system specialty pharmacies

Purpose: Adherence to self-administered biologic disease-modifying antirheumatic drugs (bDMARDs) is necessary for therapeutic benefit. Health-system specialty pharmacies (HSSPs) have reported high adherence rates across several disease states; however, adherence outcomes in rheumatoid arthritis (RA)...

Full description

Bibliographic Details
Main Authors: Canfield, S. (Author), Carter, J. (Author), Choi, L. (Author), Cowgill, N. (Author), Declercq, J. (Author), Dura, J. (Author), Gazda, N.P (Author), Gerzenshtein, L. (Author), Kehasse, A. (Author), Lach, M. (Author), Lee, J. (Author), Lewis, K. (Author), Lounsbery, B. (Author), Mccarthy, K. (Author), Ortega, M. (Author), Shah, R. (Author), Sokos, L. (Author), Stutsky, M. (Author), Thomas, K.C (Author), Thomas, T.T (Author), Wise, K. (Author), Young, J. (Author), Zuckerman, A.D (Author)
Format: Article
Language:English
Published: Oxford University Press 2021
Subjects:
abatacept
adalimumab
adult
Adult
antirheumatic agent
antirheumatic agents
Antirheumatic Agents
arthritis
Article
biological product
Biological Products
biological therapy
cohort analysis
controlled study
electronic health record
etanercept
female
Female
health care system
health insurance
human
Humans
major clinical study
male
Male
medical documentation
medicare
medication adherence
Medication Adherence
medication compliance
middle aged
Middle Aged
outcome assessment
patient referral
pharmaceutical services
Pharmacies
pharmacy
pharmacy (shop)
physician
practice guideline
prescription
Retrospective Studies
retrospective study
rheumatoid
rheumatoid arthritis
specialty pharmacy
tocilizumab
tofacitinib
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items